Back to search

Article

Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice

2025-03-13

Abstract excerpt

<h4>Background: </h4> /Objectives: Lasmiditan is a newly developed drug for the acute treatment of migraine attacks, but factors associated with its efficacy remain unclear. This study aimed to confirm the efficacy of lasmiditan started at 50 mg under various dosing conditions and identify factors associated with its efficacy. <h4>Methods:</h4> There were four reasons for prescribing lasmiditan: add-on to triptan,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2ca2e30-a55f-58d3-9e43-7e8162504656
DOI
10.20944/preprints202503.0913.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical PracticeDOI 10.20944/preprints202503.0913.v1
Recent advances in the management of migraineSemantic proximity
A Descriptive Review of Medication Overuse Headache - from Pathophysiology to the ClinicSemantic proximity
A Descriptive Review of Medication Overuse HEADACHE-from Pathophysiology to the ClinicSemantic proximity
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity
Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT <sub>1F</sub> –G protein complexSemantic proximity
Zavegepant intranasal spray for the Acute Treatment of Migraine : A Systematic Review and Meta-Analysis of Randomized Clinical TrialsSemantic proximity
An Investigation into the Prevalence of Migraine and its Prophylactic Treatment Patterns in the Czech RepublicSemantic proximity
Reduction of pain and functional disability over time in patients treated with zavegepant: A Post-hoc analysis of the BHV3500-301 Phase 3 Randomized Controlled TrialSemantic proximity
Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Real-world clinical results of CGRP monoclonal antibody treatment for medication overuse headache of migraine without abrupt drug discontinuation and no hospitalizationSemantic proximity
Fremanezumab in the Prevention of High-Frequency Episodic and Chronic Migraine: A 12-Week, Multicenter, Real-Life, Cohort Study (The FRIEND Study).Semantic proximity
Select a neighboring publication to make it the new centre.